|
Gene expression studies: dissected aorta ascendens vs. control aorta. Gene expression studies that comparing freshly dissected aorta ascendens (D) and undissected control aorta (C). 3 different gene expression studies were performed: 16 samples were studied with BD Atlas™ Human1.2 Array (h), 16 samples – with BD Atlas™ Human Cardiovascular Array (c) and 8 samples – with Affymetrix Human Genome U133A GeneChip. All differently expressed genes of the Atlas-experiments, 49 genes (h) and 33 genes (c), are shown and compared to genes of the Affymetrix experiment. Ratio: mean expression of dissected aorta (D) divided by mean expression of control (C); n.e.: not expressed, n.s.: difference not significant. n.t.: not tested, ↓ downregulated, ↑ upregulated; ? – regulation in the Atlas and Affymetrix experiment different |
||||||
| Gene Name |
Platform |
Atlas |
Affymetrix |
regulation |
||
| Functional group |
Array type |
ratio D/C |
P value |
ratio D/C |
P value |
|
|
|
||||||
| extracellular matrix proteins, |
||||||
| cell surface antigens, adhesion proteins |
||||||
| collagen IV α2, COL4A2 |
h |
0.5 |
<0.01 |
0.4 |
<0.05 |
↓ |
| collagen IV α5, COL4A5 |
n.t. |
0.32 |
<0.05 |
↓ |
||
| collagen VI α3, COL6A3 |
c |
1.9 |
<0.05 |
n.s. |
? |
|
| collagen VIII α1, COL8A1 |
c |
0.3 |
<0.01 |
0.3 |
<0.001 |
↓ |
| collagen VIII α2, COL8A2 |
n.t. |
0,4 |
<0,01 |
↓ |
||
| collagen XIV α1, COL14A1, undulin |
c |
0.4 |
<0.001 |
0.5 |
<0.001 |
↓ |
| collagen XVIII α1, COL18A1 |
n.t. |
0.47 |
<0.001 |
↓ |
||
| polycystin1, PKD1 |
h |
0.3 |
<0.001 |
0.4 |
<0.01 |
↓ |
| polycystin 2, PKD2 |
n.t. |
0.4 |
<0.001 |
↓ |
||
| clusterin, SP-40; |
h |
0.5 |
<0.01 |
0.5 |
<0.01 |
↓ |
| integrin α7B, IGA7B |
h |
0.4 |
<0.001 |
0.3 |
<0.001 |
↓ |
| gap junction protein, connexin 43 |
c |
0.6 |
<0.05 |
n.s. |
? |
|
| SPARC-like 1 |
c |
0.3 |
<0.001 |
0.6 |
<0.001 |
↓ |
| decorin |
c |
0.3 |
<0.05 |
n.s. |
↓ |
|
| elastin |
n.t. |
0.4 |
<0.05 |
↓ |
||
| fibulin 5 |
n.t. |
0.4 |
<0.001 |
↓ |
||
| cell surface glycoprotein MUC18 |
h |
0.3 |
<0.001 |
0.5 |
<0.01 |
↓ |
| fibronectin receptor |
h |
n.s. |
3.4 |
<0.01 |
↑ |
|
| ras homolog gene family member B |
h |
0.5 |
<0.05 |
n.s. |
? |
|
| extracellular matrix proteolysis |
||||||
| MMP-11 |
h |
2.1 |
<0.001 |
3.2 |
<0.05 |
↑ |
| MMP-14 |
n.t. |
2.5 |
<0.01 |
↑ |
||
| MMP-19 |
n.t. |
3.2 |
<0.05 |
↑ |
||
| TIMP1 |
h,c |
1.8 |
<0.01 |
n.s. |
? |
|
| TIMP2 |
h,c |
0.4 |
<0.01 |
n.s. |
? |
|
| TIMP3 |
c |
0.2 |
<0.001 |
n.s. |
? |
|
| cell motility and cytoskeleton proteins |
||||||
| vinculin |
c |
0.2 |
<0.001 |
n.s. |
? |
|
| actinin α1 |
c |
0.5 |
<0.001 |
0.8 |
<0.01 |
↓ |
| filamin A |
c |
0.3 |
<0.001 |
0.5 |
<0.001 |
↓ |
| actin α2 |
n.t. |
0.13 |
<0.001 |
↓ |
||
| actinin α4 |
n.t. |
0.44 |
<0.001 |
↓ |
||
| gelsolin |
n.t. |
0.5 |
<0.01 |
↓ |
||
| leiomodin |
n.t. |
0.4 |
<0.01 |
↓ |
||
| tropomyosin 1 |
n.t. |
0.4 |
<0.01 |
↓ |
||
| calponin |
n.t. |
0.3 |
<0.001 |
↓ |
||
| smooth & non-muscle myosin light chain kinase |
h |
0.4 |
<0.001 |
n.t. |
↓ |
|
| smooth muscle myosin heavy chain, SM2 |
n.t. |
0.5 |
<0.001 |
↓ |
||
| myosin regulatory light chain2, smooth muscle |
n.t. |
0.5 |
<0.001 |
↓ |
||
| metabolism |
n.t. |
|||||
| low-density lipoprotein receptor, LDLR |
c |
0.4 |
<0.001 |
1.6 |
<0.01 |
? |
| Kunitz-type serine protease inhibitor 2, SPINT2 |
h |
0.2 |
<0.001 |
0.3 |
<0.001 |
↓ |
| aldehyde dehydrogenase 2, mitochondrial |
c |
0.3 |
<0.01 |
0.6 |
<0.01 |
↓ |
| diaphorase (NADH), cytochrome b-5 reductase |
c |
0.5 |
<0.01 |
n.s. |
? |
|
| superoxide dismutase 3, extracellular |
c |
0.4 |
<0.01 |
0.4 |
<0.001 |
↓ |
| lipase A |
c |
2.6 |
<0.05 |
n.s. |
? |
|
| protease inhibit, PI1, alpha-1-antitrypsin |
h |
5.5 |
<0.001 |
↑ |
||
| GABA-B receptor 1A subunit |
h |
1.8 |
<0.001 |
n.e. |
? |
|
| prostaglandin I2 prostacyclin synthetase |
c |
0.4 |
<0.05 |
0.81 |
<0,001 |
↓ |
|
|
||||||
| Gene Name |
Platform |
Atlas |
Affymetrix |
regulation |
||
| Functional group |
Array type |
ratio D/C |
P value |
ratio D/C |
P value |
ratio D/C |
|
|
||||||
| Protein turnover |
||||||
| purine-rich element-binding protein A |
h |
0.4 |
<0.01 |
0.6 |
<0.05 |
↓ |
| glutathione S-transferase theta 1 |
h |
0.4 |
<0.01 |
0.2 |
<0.05 |
↓ |
| 58-kDa inhibit. of RNA-activated protein kinase |
h |
0.3 |
<0.01 |
↓ |
||
| G1/S-specific cyclin D1 |
h |
0.5 |
<0.01 |
n.s. |
- |
|
| carboxypeptidase H, CPE; enkephalin convertase |
h |
0.4 |
<0.01 |
↓ |
||
| ribos. protein S6 kinase II α1, S6KII-alpha 1 |
h |
3.1 |
<0.001 |
n.s. |
- |
|
| carboxypeptidase N, polypeptide 1, 50 kD |
c |
2.0 |
<0.05 |
n.e. |
- |
|
| eukariotic translation initiantion factor 4E bind prot 1 |
n.t. |
2.9 |
<0.01 |
↑ |
||
| 60 S acdic ribosomal protein PO |
n.t. |
3.0 |
<0.01 |
↑ |
||
| FOS-related antigen 1 |
h,c |
4.9 |
<0.01 |
3.6 |
<0.05 |
↑ |
| myc proto-oncogene |
h |
3.5 |
<0.01 |
2.8 |
<0.05 |
↑ |
| ets domain protein elk-3; NET; SRF accessory protein |
h |
2.1 |
<0.001 |
4.4 |
<0.05 |
↑ |
| adenine phosphoribosyltransferase |
n.t. |
2.1 |
<0.001 |
↑ |
||
| high mobility group prot isoforms I & Y, HMGIY |
h |
10.1 |
<0.001 |
6,0 |
<0.01 |
↑ |
| superoxide dismutase 2, mitochondrial |
c |
2.6 |
<0.01 |
3.7 |
<0.001 |
↑ |
| Cell receptors |
||||||
| Natriuretic peptide receptor A/guanylate cyclase A |
c |
0.4 |
<0.001 |
0.3 |
<0.001 |
↓ |
| natriuretic peptide receptor C/guanylate cyclase C |
c |
0.5 |
<0.001 |
n.s. |
- |
|
| protein tyrosine phosphatase receptor type F |
c,h |
0.4 |
<0.01 |
n.t. |
- |
|
| growth factors |
||||||
| vascular endothelial growth factor, VEGF |
h |
4.7 |
<0.05 |
n.s. |
- |
|
| endothelin 2 |
c |
0.6 |
<0.01 |
n.e. |
- |
|
| fibroblast growth factor receptor1 |
h |
0.6 |
<0.01 |
0.7 |
<0.05 |
↓ |
| insulin-like growth factor-binding protein 2, IGFBP2 |
h |
0.3 |
<0.001 |
0.2 |
<0.01 |
↓ |
| cardiotrophin 1 |
c |
0.4 |
<0.001 |
0.5 |
>0.05 |
↓ |
| pleiotrophin, heparin-binding growth factor 8, HBGF8 |
h |
0.5 |
<0.05 |
0.6 |
<0.05 |
↓ |
| inflammation + stress response |
||||||
| colony-stimulating factor 1 receptor, CSF1R |
h |
2.0 |
<0.05 |
1.7 |
<0.05 |
↑ |
| myeloid cell nuclear differentiation antigen |
h |
3.5 |
<0.001 |
3.9 |
<0.05 |
↑ |
| tumor necrosis fact recept superfam memb 1B |
h |
2.0 |
<0.001 |
n.s. |
- |
|
| granulocyte colony stimul factor recept |
h |
3.5 |
<0.01 |
n.e. |
- |
|
| interleukin 2 receptor alpha subunit, IL-2, CD25 antigen |
h |
3.1 |
<0.001 |
5.3 |
<0.001 |
↑ |
| interleukin 6, IL-6 |
h |
3.9 |
<0.01 |
4.3 |
<0.001 |
↑ |
| interleukin 8, IL-8 |
12.2 |
<0.05 |
↑ |
|||
| small inducible cytokine subfamily A member 2 |
h,c |
3.8 |
<0.01 |
2.2 |
<0.05 |
↑ |
| 90-kDa heat-shock proteinA HSP90A |
h |
2.6 |
<0.05 |
n.t. |
↑ |
|
| 60-kDa heat shock protein HSP60 |
h |
2.7 |
<0.05 |
n.t. |
↑ |
|
| CD9 antigen p24 |
c |
0.5 |
<0.001 |
0.5 |
<0.01 |
↓ |
| 27-kDa heat shock protein HSP27 |
h |
0.4 |
<0.001 |
n.t. |
- |
|
| blood, hemostasis |
||||||
| endothelial plasminogen activator inhibit 1, PAI1 |
h |
2.8 |
<0.05 |
4.0 |
<0.05 |
↑ |
| thrombomodulin |
h |
2.8 |
<0.05 |
n.s. |
- |
|
| hexabrachion, tenascin C |
c |
2.6 |
<0.01 |
6.2 |
<0.05 |
↑ |
| heme oxygenase 1 |
h |
15.4 |
<0.05 |
3.6 |
<0.05 |
↑ |
| tissue factor pathway inhibit, coagulation inhibit |
c |
2.0 |
<0.05 |
1.6 |
<0.05 |
↑ |
| tissue factor pathway inhibitor 2 |
c |
2.3 |
<0.05 |
3.0 |
<0.05 |
↑ |
| others |
||||||
| c-fgr proto-oncogene p55-FGR |
h |
2.6 |
<0.01 |
2.6 |
<0.01 |
↑ |
| erbB3 proto-oncogene; HER3 |
h |
3.7 |
<0.001 |
n.t. |
↑ |
|
| caspase 4 |
h |
1.9 |
<0.05 |
n.t. |
↑ |
|
| follistatin-related protein |
h |
0.5 |
<0.01 |
0.6 |
<0.01 |
↓ |
| Gem; induced immediate early protein |
h |
0.2 |
<0.001 |
0.3 |
<0.001 |
↓ |
| parathymosin athymosin |
h |
0.6 |
<0.05 |
0.8 |
n.s. |
- |
| prostaglandin I2 (prostacyclin) synthase |
c |
0.4 |
<0.05 |
n.t. |
<0.001 |
↓ |
| calcium-activated potassium channel beta subunit |
h |
0.3 |
<0.001 |
0.4 |
<0.01 |
↓ |
| solute carrier fam 4 anion exchanger member 3 |
c |
0.5 |
<0.001 |
n.t. |
- |
|
Weis-Müller et al. Journal of Translational Medicine 2006 4:29 doi:10.1186/1479-5876-4-29 |
||||||